Rejected at 8:12 a.m. Apr, 22, 2026 ] by Ahmed7
Author: justinjkim
Related Note: 1502087562746
Rationale for change

Based on the FDA drug label, ivabradine may cause hypotension (not hypertension): https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92018a65-38f6-45f7-91d4-a34921b81d0d

Under adverse reactions:

6.2 Postmarketing Experience
Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or establish a causal relationship to drug exposure.

The following adverse reactions have been identified in adults during post-approval use of Corlanor: syncope, hypotension, torsade de pointes, ventricular fibrillation, ventricular tachycardia, angioedema, erythema, rash, pruritus, urticaria, vertigo, and diplopia, and visual impairment.

Rejection reason

see comments

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::16_Ivabradine #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::05_Ivabradine #AK_Other::^EXPN #AK_Other::Only_Step_1 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::06_Drugs_for_Heart_Failure #AK_Step1_v12::#OME::PreClinical::Cardiac #AK_Step1_v12::#Pixorize::03_Pharmacology::22_Cardiovascular_(New)::01_Ivabradine #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#B&B::02_Cardio::05_Pharm::02_Cardiovascular_Pharmacology_II #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::06_Class_V_Antiarrhythmics #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::22_Ivabradine #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::FA-Cardio #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::01_Heart_Failure_Drugs::03_Sacubitril-Valsartan_Milrinone_Nesiritide_Ivabradine #AK_Step1_v12::#Low/HighYield::3-HighYield-temporary